Table 1.
Baseline demographic and clinical data of study patients
| Mean±SD or n | ||
|---|---|---|
| Age (years) | 67.5±8.5 | |
| Gender (male/female) | 37/10 | |
| Cirrhotic background | 45/47 | |
| HBV | 34 | |
| HCV | 5 | |
| HBV+HCV | 1 | |
| HBV+HDV | 1 | |
| Alcohol usage | 2 | |
| Unknown | 2 | |
| Child-Pugh classification | ||
| A | 34 | |
| B | 13 | |
| BCLC stagea | ||
| A | 3 | |
| B | 36 | |
| C | 8 | |
| Tumor number | ||
| Solitary | 14 | |
| Two | 12 | |
| Three | 10 | |
| Four or more | 11 | |
| Maximum diameter of targets (mm) | ||
| Minimum | 23 | |
| Maximum | 163 | |
| Mean | 73 | |
| Median | 61 | |
| Tumor burden | ||
| >50% | 6 | |
| <50% | 41 | |
| Macrovascular invasion | ||
| Yes | 9 | |
| No | 38 | |
a
BCLC, Barcelona Clinic Liver Cancer stage. BCLC-A, patients of this study were unsuitable for curative treatment; BCLC-C, patients of this study had partial or peripheral portal vein thrombosis or hilar or perihepatic lymph node involvement.
HBV, hepatitis B virus; HCV, hepatitis C virus; HDV, hepatitis delta virus; SD, standard deviation.